{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:22Z","timestamp":1790812822694,"version":"4.1.0"},"reference-count":182,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:00:00Z","timestamp":1552435200000},"content-version":"vor","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","onlinejacc.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jacc.2018.01.017","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T19:07:19Z","timestamp":1520276839000},"page":"1149-1166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Spectrum of Restrictive and Infiltrative\u00a0Cardiomyopathies"],"prefix":"10.1016","volume":"71","author":[{"given":"Naveen L.","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Grogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. William","family":"Dec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2018.01.017_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.01.017_bib2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1056\/NEJM199701233360407","article-title":"Restrictive cardiomyopathy","volume":"336","author":"Kushwaha","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib3","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1161\/CIRCULATIONAHA.107.701367","article-title":"Carcinoid heart disease","volume":"116","author":"Bhattacharyya","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.01.017_bib4","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1161\/CIRCULATIONAHA.115.021178","article-title":"Tropical endomyocardial fibrosis: natural history, challenges, and perspectives","volume":"133","author":"Grimaldi","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.01.017_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa0708629","article-title":"A\u00a0population study of endomyocardial fibrosis in a rural area of Mozambique","volume":"359","author":"Mocumbi","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib6","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/hrt.2007.136101","article-title":"Neglected tropical cardiomyopathies: II. Endomyocardial fibrosis: myocardial disease","volume":"94","author":"Mocumbi","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2018.01.017_bib7","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1371\/journal.pntd.0000661","article-title":"Presence of circulating anti-myosin antibodies in endomyocardial fibrosis","volume":"4","author":"Mocumbi","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jacc.2018.01.017_bib8","first-page":"470","article-title":"Serum immunoglobulins in patients with endomyocardial fibrosis","volume":"38","author":"Mathai","year":"1986","journal-title":"Indian Heart J"},{"key":"10.1016\/j.jacc.2018.01.017_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0001-706X(97)00125-3","article-title":"Helminth associated hypereosinophilia and tropical endomyocardial fibrosis (EMF) in Nigeria","volume":"69","author":"Andy","year":"1998","journal-title":"Acta Trop"},{"key":"10.1016\/j.jacc.2018.01.017_bib10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/156482650202300418","article-title":"Chronic poisoning by hydrogen cyanide in cassava and its prevention in Africa and Latin America","volume":"23","author":"Teles","year":"2002","journal-title":"Food Nutr Bull"},{"key":"10.1016\/j.jacc.2018.01.017_bib11","first-page":"405","article-title":"Current perspective on endomyocardial fibrosis","volume":"97","author":"Tharakan","year":"2009","journal-title":"Curr Sci"},{"key":"10.1016\/j.jacc.2018.01.017_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0140-6736(96)90383-9","article-title":"Endomyocardial fibrosis: why is there striking ascites with little or no peripheral oedema?","volume":"347","author":"Freers","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2018.01.017_bib13","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/clc.20220","article-title":"Ascites in tropical endomyocardial fibrosis","volume":"30","author":"Desser","year":"2007","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib14","first-page":"129","article-title":"Electrocardiogram in endomyocardial fibrosis","volume":"11","author":"Tharakan","year":"2011","journal-title":"Indian Pacing Electrophysiol J"},{"key":"10.1016\/j.jacc.2018.01.017_bib15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/hrt.25.4.502","article-title":"Intracardiac thrombosis and embolism in endomyocardial fibrosis in Uganda","volume":"25","author":"Shaper","year":"1963","journal-title":"Br Heart J"},{"key":"10.1016\/j.jacc.2018.01.017_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0894-7317(00)70008-3","article-title":"Usefulness of echocardiography and doppler echocardiography in endomyocardial fibrosis","volume":"13","author":"Berensztein","year":"2000","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jacc.2018.01.017_bib17","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1378\/chest.128.6.3985","article-title":"Pitfalls in diagnosis and clinical, echocardiographic, and hemodynamic findings in endomyocardial fibrosis: a 25-year experience","volume":"128","author":"Hassan","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2018.01.017_bib18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.repc.2011.12.016","article-title":"Usefulness of CMR in the early diagnosis of endomyocardial fibrosis","volume":"31","author":"Leon","year":"2012","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib19","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/hrt.79.4.362","article-title":"Long-term follow up of patients with endomyocardial fibrosis: effects of surgery","volume":"79","author":"Schneider","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2018.01.017_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1067\/mtc.2003.70","article-title":"New approach for complete endocardiectomy in left ventricular endomyocardial fibrosis","volume":"125","author":"Joshi","year":"2003","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2018.01.017_bib21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0002-9149(88)90972-1","article-title":"Natural history and prognostic risk factors in endocardial fibroelastosis","volume":"62","author":"Ino","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib22","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMcpc1302331","article-title":"Case records of the Massachusetts General Hospital. Case 7-2014. A 27-year-old man with diarrhea, fatigue, and eosinophilia","volume":"370","author":"Fathi","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaci.2010.03.035","article-title":"Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence","volume":"126","author":"Crane","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jacc.2018.01.017_bib24","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood.V83.10.2759.2759","article-title":"The idiopathic hypereosinophilic syndrome","volume":"83","author":"Weller","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2018.01.017_bib25","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1182\/blood-2014-02-555607","article-title":"Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib","volume":"123","author":"Cheah","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2018.01.017_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0002-9149(00)00841-9","article-title":"Clinical and echocardiographic features of hypereosinophilic syndromes","volume":"86","author":"Ommen","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ahj.2005.08.021","article-title":"Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation","volume":"152","author":"Srichai","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2018.01.017_bib28","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.ijcard.2007.01.019","article-title":"Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease","volume":"126","author":"Syed","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib29","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood-2006-02-004945","article-title":"Eosinophils are a major intravascular location for tissue factor storage and exposure","volume":"109","author":"Moosbauer","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2018.01.017_bib30","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jacc.2018.01.017_bib31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/j.seminhematol.2012.01.001","article-title":"Treatment of hypereosinophilic syndromes\u2014the first 100 years","volume":"49","author":"Butterfield","year":"2012","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jacc.2018.01.017_bib32","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0003-4975(91)91034-S","article-title":"Mitral valve replacement in idiopathic hypereosinophilic syndrome","volume":"51","author":"Boustany","year":"1991","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2018.01.017_bib33","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.cardfail.2010.05.009","article-title":"Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment","volume":"16","author":"Murphy","year":"2010","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2018.01.017_bib34","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jacc.2010.03.083","article-title":"Iron overload cardiomyopathy: betterunderstanding of an increasing disorder","volume":"56","author":"Gujja","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib35","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.111.050773","article-title":"Iron overload cardiomyopathy in clinical practice","volume":"124","author":"Kremastinos","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.01.017_bib36","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJM199912233412607","article-title":"Disorders of iron metabolism","volume":"341","author":"Andrews","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib37","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0891-5849(02)00772-4","article-title":"Molecular bases of cellular iron toxicity","volume":"32","author":"Eaton","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib38","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nm920","article-title":"L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy","volume":"9","author":"Oudit","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib39","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.RES.84.11.1302","article-title":"Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload","volume":"84","author":"Tsushima","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2018.01.017_bib40","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1161\/01.CIR.88.3.1127","article-title":"Left ventricular diastolic Doppler characteristics in beta-thalassemia major","volume":"88","author":"Kremastinos","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.01.017_bib41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00877096","article-title":"Iron overload cardiomyopathies: new insights into an old disease","volume":"8","author":"Liu","year":"1994","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2018.01.017_bib42","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199409013310903","article-title":"Survival in medically treated patients with homozygous beta-thalassemia","volume":"331","author":"Olivieri","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib43","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJM199409013310902","article-title":"Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major","volume":"331","author":"Brittenham","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/01.CIR.82.1.88","article-title":"Restrictive diastolic abnormalities identified by Doppler echocardiography in patients with thalassemia major","volume":"82","author":"Spirito","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.01.017_bib45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pcad.2007.10.003","article-title":"Sudden cardiac death in infiltrative cardiomyopathies: sarcoidosis, scleroderma, amyloidosis, hemachromatosis","volume":"51","author":"Lubitz","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2018.01.017_bib46","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1067\/mje.2002.118032","article-title":"The role of Doppler left ventricular filling indexes and Doppler tissue echocardiography in the assessment of cardiac involvement in hereditary hemochromatosis","volume":"15","author":"Palka","year":"2002","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jacc.2018.01.017_bib47","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ejheart.2006.11.004","article-title":"NT-proBNP levels and diastolic dysfunction in beta-thalassaemia major patients","volume":"9","author":"Kremastinos","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2018.01.017_bib48","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ahj.2009.10.025","article-title":"Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major","volume":"159","author":"Kremastinos","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2018.01.017_bib49","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1527-5299.2001.00259.x","article-title":"Heart failure in beta-thalassemia","volume":"7","author":"Kremastinos","year":"2001","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.jacc.2018.01.017_bib50","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/0003-4819-143-7-200510040-00010","article-title":"Screening for hereditary hemochromatosis: a clinical practice guideline from the American College of Physicians","volume":"143","author":"Qaseem","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib51","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-133-5-200009050-00008","article-title":"The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic","volume":"133","author":"Beutler","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib52","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/jama.296.3.310","article-title":"N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease","volume":"296","author":"Machado","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2018.01.017_bib53","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.amjcard.2008.03.066","article-title":"Relation between iron-overload indices, cardiac echo-Doppler, and biochemical markers in thalassemia intermedia","volume":"102","author":"Isma'eel","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib54","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCHEARTFAILURE.109.913863","article-title":"Beta-thalassemia cardiomyopathy: history, present considerations, and future perspectives","volume":"3","author":"Kremastinos","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2018.01.017_bib55","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.euje.2006.02.004","article-title":"Use of strain and tissue velocity imaging for early detection of regional myocardial dysfunction in patients with beta thalassemia","volume":"8","author":"Hamdy","year":"2007","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.jacc.2018.01.017_bib56","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.euje.2004.01.003","article-title":"Biventricular diastolic behaviour in patients with hypertrophic and hereditary hemochromatosis cardiomyopathies","volume":"5","author":"Palka","year":"2004","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.jacc.2018.01.017_bib57","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.amjcard.2006.04.040","article-title":"Significance of left atrial contractile function in asymptomatic subjects with hereditary hemochromatosis","volume":"98","author":"Shizukuda","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib58","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1161\/CIRCULATIONAHA.106.647172","article-title":"Role of tissue Doppler and strain echocardiography in current clinical practice","volume":"116","author":"Abraham","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.01.017_bib59","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1540-8175.2009.00956.x","article-title":"Does oxidative stress modulate left ventricular diastolic function in asymptomatic subjects with hereditary hemochromatosis?","volume":"26","author":"Shizukuda","year":"2009","journal-title":"Echocardiography"},{"key":"10.1016\/j.jacc.2018.01.017_bib60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1532-429X-13-15","article-title":"The relative atrial volume ratio and late gadolinium enhancement provide additive information to differentiate constrictive pericarditis from restrictive cardiomyopathy","volume":"13","author":"Cheng","year":"2011","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jacc.2018.01.017_bib61","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","article-title":"Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload","volume":"22","author":"Anderson","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.01.017_bib62","doi-asserted-by":"crossref","first-page":"E55","DOI":"10.1002\/clc.20310","article-title":"Quantification of myocardial iron overload by cardiovascular magnetic resonance imaging T2* and review of the literature","volume":"32","author":"Kondur","year":"2009","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib63","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1161\/CIRCULATIONAHA.109.874487","article-title":"Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major","volume":"120","author":"Kirk","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.01.017_bib64","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1161\/CIRCULATIONAHA.109.907196","article-title":"History and current impact of cardiac magnetic resonance imaging on the management of iron overload","volume":"120","author":"Wood","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.01.017_bib65","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/(SICI)1522-2586(199911)10:5<609::AID-JMRI4>3.0.CO;2-2","article-title":"MRI myocardial tagging","volume":"10","author":"Reichek","year":"1999","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1016\/j.jacc.2018.01.017_bib66","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jmr.2005.05.010","article-title":"DENSE with SENSE","volume":"176","author":"Aletras","year":"2005","journal-title":"J\u00a0Magn Reson"},{"key":"10.1016\/j.jacc.2018.01.017_bib67","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1600-0609.1989.tb01229.x","article-title":"Myocardial iron grading by endomyocardial biopsy. A clinico-pathologic study on iron overloaded patients","volume":"42","author":"Barosi","year":"1989","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jacc.2018.01.017_bib68","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMra031573","article-title":"Hereditary hemochromatosis\u2014a new look at an old disease","volume":"350","author":"Pietrangelo","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib69","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/0002-9149(83)90422-8","article-title":"Cardiac hemochromatosis: beneficial effects of iron removal therapy. An echocardiographic study","volume":"52","author":"Candell-Riera","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib70","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0002-8703(87)90039-1","article-title":"Reversible cardiac dysfunction in hemochromatosis","volume":"113","author":"Rivers","year":"1987","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2018.01.017_bib71","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMct1004810","article-title":"Iron-chelating therapy for transfusional iron overload","volume":"364","author":"Brittenham","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib72","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1532-429X-10-42","article-title":"Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance","volume":"10","author":"Modell","year":"2008","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jacc.2018.01.017_bib73","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0609.2007.01018.x","article-title":"The heart in transfusion dependent homozygous thalassaemia today\u2014prediction, prevention and management","volume":"80","author":"Aessopos","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jacc.2018.01.017_bib74","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/BF03006922","article-title":"Intensive chelation therapy in beta-thalassemia and possible adverse cardiac effects of desferrioxamine","volume":"86","author":"Aessopos","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jacc.2018.01.017_bib75","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2004.05202.x","article-title":"Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance","volume":"127","author":"Anderson","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jacc.2018.01.017_bib76","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1182\/blood-2009-04-217455","article-title":"Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia","volume":"115","author":"Pennell","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2018.01.017_bib77","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2005-07-2948","article-title":"Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis","volume":"107","author":"Pennell","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2018.01.017_bib78","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.106.648790","article-title":"A\u00a0randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance","volume":"115","author":"Tanner","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.01.017_bib79","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1161\/01.CIR.0000124229.40424.80","article-title":"Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model","volume":"109","author":"Oudit","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.01.017_bib80","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/blood-2012-07-440743","article-title":"Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis","volume":"120","author":"Ramos","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2018.01.017_bib81","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrd.2016.248","article-title":"Targeting iron metabolism in drug discovery and delivery","volume":"16","author":"Crielaard","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jacc.2018.01.017_bib82","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.healun.2004.02.009","article-title":"Cardiac transplantation in patients with iron overload cardiomyopathy","volume":"24","author":"Caines","year":"2005","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2018.01.017_bib83","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2008.09.009","article-title":"Cardiac sarcoidosis","volume":"157","author":"Kim","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2018.01.017_bib84","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrcardio.2015.22","article-title":"Pathophysiology and clinical management of cardiac sarcoidosis","volume":"12","author":"Hamzeh","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib85","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib86","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","article-title":"Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib87","first-page":"167","article-title":"Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations","volume":"119","author":"Perry","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib88","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"Valeyre","year":"2014","journal-title":"Sarcoidosis. Lancet"},{"key":"10.1016\/j.jacc.2018.01.017_bib89","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1164\/ajrccm.164.11.2106001","article-title":"Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS)","volume":"164","author":"Rybicki","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib90","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1034\/j.1399-0039.2000.560107.x","article-title":"HLA-DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis","volume":"56","author":"Naruse","year":"2000","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jacc.2018.01.017_bib91","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1086\/378097","article-title":"HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites","volume":"73","author":"Rossman","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacc.2018.01.017_bib92","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1164\/ajrccm.165.8.200110-0320","article-title":"Increased frequency of the uncommon tumor necrosis factor-857T allele in British and Dutch patients with sarcoidosis","volume":"165","author":"Grutters","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib93","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1519","article-title":"Sarcoidosis is associated with a truncating splice site mutation in BTNL2","volume":"37","author":"Valentonyte","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2018.01.017_bib94","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib95","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.amjcard.2013.11.015","article-title":"Morphologic features of cardiac sarcoidosis in native hearts of patients having cardiac transplantation","volume":"113","author":"Roberts","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib96","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003738","article-title":"Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance","volume":"9","author":"Murtagh","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2018.01.017_bib97","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.01.017_bib98","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/jce.12401","article-title":"Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults","volume":"25","author":"Nery","year":"2014","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib99","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/pace.12277","article-title":"Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia","volume":"37","author":"Nery","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2796.2011.02396.x","article-title":"Diagnosing isolated cardiac sarcoidosis","volume":"270","author":"Kandolin","year":"2011","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib101","first-page":"178","article-title":"Sarcoidosis presenting as heart disease","volume":"13","author":"Nelson","year":"1996","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.jacc.2018.01.017_bib102","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","article-title":"Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11)","volume":"63","author":"Roberts","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib103","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1378\/chest.128.1.30","article-title":"Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands","volume":"128","author":"Smedema","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2018.01.017_bib104","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib105","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.hfc.2005.06.004","article-title":"Giant cell and granulomatous myocarditis","volume":"1","author":"Cooper","year":"2005","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.jacc.2018.01.017_bib106","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jtcvs.2004.03.048","article-title":"Sarcoidosis of the aortic root","volume":"128","author":"Gasparovic","year":"2004","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2018.01.017_bib107","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0002-8703(97)70070-X","article-title":"Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block","volume":"134","author":"Yoshida","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2018.01.017_bib108","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCEP.110.959254","article-title":"Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults","volume":"4","author":"Kandolin","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib109","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.amjcard.2014.01.434","article-title":"Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias","volume":"113","author":"Cain","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib110","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0735-1097(91)90750-4","article-title":"Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device","volume":"18","author":"Winters","year":"1991","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib111","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.hrthm.2006.03.031","article-title":"Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation","volume":"3","author":"Koplan","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2018.01.017_bib112","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/europace\/eun110","article-title":"Ventricular tachyarrhythmia as a primary presentation of sarcoidosis","volume":"10","author":"Uusimaa","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2018.01.017_bib113","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/CIRCEP.113.000734","article-title":"Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis","volume":"7","author":"Naruse","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib114","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCEP.113.000156","article-title":"Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias","volume":"7","author":"Crawford","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib115","first-page":"448","article-title":"Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosis","volume":"60","author":"Shafee","year":"2012","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib116","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.amjcard.2015.06.021","article-title":"Usefulness of cardiac troponins as markers of early treatment response in cardiac sarcoidosis","volume":"116","author":"Kandolin","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib117","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib118","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.rmed.2014.11.009","article-title":"ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy","volume":"109","author":"Vorselaars","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib119","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing","volume":"133","author":"Mehta","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2018.01.017_bib120","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1540-8167.2011.02099.x","article-title":"Electrocardiographic characteristics in patients with pulmonary sarcoidosis indicating cardiac involvement","volume":"22","author":"Schuller","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib121","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1542-474X.2009.00320.x","article-title":"Fragmented QRS complexes on 12-lead ECG: a marker of cardiac sarcoidosis as detected by gadolinium cardiac magnetic resonance imaging","volume":"14","author":"Homsi","year":"2009","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib122","doi-asserted-by":"crossref","first-page":"1015.e1","DOI":"10.1016\/j.cjca.2012.09.009","article-title":"Isolated cardiac sarcoidosis: establishing the diagnosis with electroanatomic mapping-guided endomyocardial biopsy","volume":"29","author":"Nery","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib123","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.01.017_bib124","first-page":"325","article-title":"Cardiovascular magnetic resonance-guided diagnosis of cardiac affection in a Caucasian sarcoidosis population","volume":"32","author":"Pizarro","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.jacc.2018.01.017_bib125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1378\/chest.109.1.62","article-title":"Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis","volume":"109","author":"Fahy","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2018.01.017_bib126","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/hrt.2003.027763","article-title":"Early detection of cardiac involvement in patients with sarcoidosis by a non-invasive method with ultrasonic tissue characterisation","volume":"90","author":"Hyodo","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2018.01.017_bib127","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2796.2002.01058.x","article-title":"Determination of cardiac involvement in sarcoidosis by magnetic resonance imaging and Doppler echocardiography","volume":"252","author":"Skold","year":"2002","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ejhf.205","article-title":"Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis","volume":"17","author":"Joyce","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2018.01.017_bib129","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2005.01.047","article-title":"Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis","volume":"45","author":"Smedema","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2214\/ajr.184.1.01840249","article-title":"Cardiac sarcoidosis: spectrum of MRI features","volume":"184","author":"Vignaux","year":"2005","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacc.2018.01.017_bib131","doi-asserted-by":"crossref","first-page":"862","DOI":"10.2214\/AJR.07.3089","article-title":"MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function","volume":"191","author":"Ichinose","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacc.2018.01.017_bib132","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/eurjhf\/hfs206","article-title":"Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure","volume":"15","author":"Yoshida","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2018.01.017_bib133","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1378\/chest.122.6.1895","article-title":"Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study","volume":"122","author":"Vignaux","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2018.01.017_bib134","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2018.01.017_bib135","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/heartjnl-2013-305187","article-title":"Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis","volume":"100","author":"Ise","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2018.01.017_bib136","first-page":"1522","article-title":"Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG","volume":"46","author":"Pellegrino","year":"2005","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib137","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/eurheartj\/ehi180","article-title":"Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis","volume":"26","author":"Ishimaru","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.01.017_bib138","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib139","first-page":"1030","article-title":"Identification of cardiac sarcoidosis with (13)N-NH(3)\/(18)F-FDG PET","volume":"44","author":"Yamagishi","year":"2003","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib140","first-page":"1989","article-title":"Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis","volume":"45","author":"Okumura","year":"2004","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib141","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1161\/CIRCULATIONAHA.105.594200","article-title":"Images in cardiovascular medicine. Multimodality imaging of cardiac sarcoidosis before and after steroid therapy","volume":"113","author":"Tadamura","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.01.017_bib142","first-page":"466","article-title":"Electrogram guidance: a method to increase the precision and diagnostic yield of endomyocardial biopsy for suspected cardiac sarcoidosis and myocarditis","volume":"2","author":"Liang","year":"2014","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2018.01.017_bib143","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.carpath.2011.10.001","article-title":"2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology","volume":"21","author":"Leone","year":"2012","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jacc.2018.01.017_bib144","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1378\/chest.11-0263","article-title":"Management of cardiac sarcoidosis in the United States: a Delphi study","volume":"141","author":"Hamzeh","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2018.01.017_bib145","first-page":"320","article-title":"Recovery of atrioventricular block following steroid therapy in patients with cardiac sarcoidosis","volume":"62","author":"Yodogawa","year":"2013","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib146","first-page":"133","article-title":"Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block","volume":"20","author":"Kato","year":"2003","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.jacc.2018.01.017_bib147","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1542-474X.2011.00418.x","article-title":"Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"16","author":"Yodogawa","year":"2011","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib148","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2018.01.017_bib149","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.cjca.2013.02.004","article-title":"Corticosteroid therapy for cardiac sarcoidosis: a systematic review","volume":"29","author":"Sadek","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.amjcard.2004.08.083","article-title":"Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis","volume":"95","author":"Chiu","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib151","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.hrthm.2007.06.006","article-title":"Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis","volume":"4","author":"Banba","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2018.01.017_bib152","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1183\/09031936.06.00105805","article-title":"Corticosteroid treatment in sarcoidosis","volume":"28","author":"Grutters","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2018.01.017_bib153","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.2169\/internalmedicine.53.3120","article-title":"Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions","volume":"53","author":"Nagai","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib154","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.rmed.2014.09.013","article-title":"Efficacy of mycophenolate mofetil in sarcoidosis","volume":"108","author":"Hamzeh","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib155","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1183\/09031936.99.14511179","article-title":"Treatment of chronic sarcoidosis with an azathioprine\/prednisolone regimen","volume":"14","author":"Muller-Quernheim","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2018.01.017_bib156","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1378\/chest.94.1.202","article-title":"Myocardial sarcoidosis unresponsive to steroids. Treatment with cyclophosphamide","volume":"94","author":"Demeter","year":"1988","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2018.01.017_bib157","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1183\/09031936.00051907","article-title":"Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial","volume":"31","author":"Judson","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2018.01.017_bib158","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.rmed.2016.04.011","article-title":"Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab","volume":"115","author":"Crommelin","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.jacc.2018.01.017_bib159","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12948-015-0025-9","article-title":"Rituximab in refractory sarcoidosis: a single centre experience","volume":"13","author":"Cinetto","year":"2015","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.jacc.2018.01.017_bib160","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.jacc.2012.12.014","volume":"61","author":"Epstein","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib161","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCEP.110.958322","article-title":"Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation","volume":"4","author":"Mehta","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib162","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1540-8167.2012.02350.x","article-title":"Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis","volume":"23","author":"Schuller","year":"2012","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib163","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/eus316","article-title":"Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"15","author":"Kron","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2018.01.017_bib164","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/CIRCEP.114.002145","article-title":"Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation","volume":"8","author":"Kumar","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib165","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.transproceed.2013.02.116","article-title":"Heart transplantation for end-stage heart failure due to cardiac sarcoidosis","volume":"45","author":"Perkel","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jacc.2018.01.017_bib166","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.healun.2007.05.006","article-title":"Outcome of heart transplantation in patients with sarcoid cardiomyopathy","volume":"26","author":"Zaidi","year":"2007","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2018.01.017_bib167","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.healun.2005.02.016","article-title":"Recurrence of cardiac sarcoidosis in a heart transplant recipient","volume":"24","author":"Yager","year":"2005","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2018.01.017_bib168","doi-asserted-by":"crossref","first-page":"e5932","DOI":"10.1097\/MD.0000000000005932","article-title":"Late onset radiation-induced constrictive pericarditis and cardiomyopathy after radiotherapy: a case report","volume":"96","author":"Zhuang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacc.2018.01.017_bib169","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ijrobp.2009.09.064","article-title":"Radiation-related heart disease: current knowledge and future prospects","volume":"76","author":"Darby","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jacc.2018.01.017_bib170","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.radonc.2010.08.010","article-title":"Late radiation-induced heart disease after radiotherapy. Clinical importance, radiobiological mechanisms and strategies of prevention","volume":"100","author":"Andratschke","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jacc.2018.01.017_bib171","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2018.01.017_bib172","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.radonc.2011.06.016","article-title":"Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden","volume":"100","author":"McGale","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jacc.2018.01.017_bib173","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/CIRCULATIONAHA.116.025434","article-title":"Risk of heart failure with preserved ejection fraction in older women after contemporary radiotherapy for breast cancer","volume":"135","author":"Saiki","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.01.017_bib174","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0967-2109(96)82320-9","article-title":"Changes in the proportion of types I and III collagen in the left ventricular wall of patients with post-irradiative pericarditis","volume":"4","author":"Chello","year":"1996","journal-title":"Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2018.01.017_bib175","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/cncr.22965","article-title":"Prospective assessment of radiotherapy-associated cardiac toxicity in breast cancer patients: analysis of data 3 to 6 years after treatment","volume":"110","author":"Prosnitz","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jacc.2018.01.017_bib176","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0735-1097(03)00759-9","article-title":"Asymptomatic cardiac disease following mediastinal irradiation","volume":"42","author":"Heidenreich","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2018.01.017_bib177","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.ijrobp.2012.09.022","article-title":"Subclinical cardiotoxicity detected by strain rate imaging up to 14\u00a0months after breast radiation therapy","volume":"85","author":"Erven","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jacc.2018.01.017_bib178","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1200\/JCO.2004.09.109","article-title":"Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy","volume":"22","author":"Adams","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jacc.2018.01.017_bib179","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/ehjci\/jet123","article-title":"Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"14","author":"Lancellotti","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2018.01.017_bib180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ejhf.654","article-title":"2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for Cancer Treatments and Cardiovascular Toxicity of the European Society of Cardiology (ESC)","volume":"19","author":"Zamorano","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2018.01.017_bib181","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.athoracsur.2014.06.056","article-title":"Cardiac transplantation for radiation-induced cardiomyopathy: the Mayo Clinic experience","volume":"98","author":"Saxena","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2018.01.017_bib182","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cardfail.2016.03.014","article-title":"Heart transplantation outcomes in radiation-induced restrictive cardiomyopathy","volume":"22","author":"Al-Kindi","year":"2016","journal-title":"J\u00a0Card Fail"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109718301220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109718301220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:12:13Z","timestamp":1603930333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109718301220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":182,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0735109718301220"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2018.01.017","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spectrum of Restrictive and Infiltrative\u00a0Cardiomyopathies","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2018.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2018.01.016","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}